Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1915
9.450
 Why?
Anti-Asthmatic Agents
28
2025
274
3.300
 Why?
Adrenal Cortex Hormones
28
2025
500
3.280
 Why?
Forced Expiratory Volume
19
2019
493
1.530
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1075
1.320
 Why?
Severity of Illness Index
20
2020
2926
0.950
 Why?
Administration, Inhalation
25
2025
592
0.940
 Why?
Anti-Inflammatory Agents
10
2016
483
0.850
 Why?
Albuterol
5
2015
74
0.830
 Why?
Bronchodilator Agents
12
2016
194
0.820
 Why?
Lung Transplantation
10
2017
336
0.790
 Why?
Budesonide
14
2016
55
0.790
 Why?
Remote Consultation
4
2025
66
0.730
 Why?
Nedocromil
11
2016
23
0.710
 Why?
Humans
129
2025
143821
0.690
 Why?
Nasal Polyps
1
2021
61
0.680
 Why?
Self Report
3
2023
865
0.670
 Why?
Endpoint Determination
2
2020
82
0.660
 Why?
Pharmacogenetics
2
2015
170
0.660
 Why?
Food Hypersensitivity
1
2022
168
0.630
 Why?
Sinusitis
1
2021
237
0.580
 Why?
Virus Diseases
1
2021
217
0.570
 Why?
Lung
7
2019
4143
0.560
 Why?
Glucocorticoids
4
2022
539
0.560
 Why?
Physicians
2
2021
932
0.560
 Why?
Symptom Assessment
1
2019
130
0.550
 Why?
Hospitalization
13
2020
2340
0.540
 Why?
Sleep Apnea, Obstructive
1
2021
320
0.510
 Why?
Androstadienes
3
2012
79
0.500
 Why?
Bone Density
2
2014
501
0.490
 Why?
Child
53
2022
22440
0.490
 Why?
Oxygen Inhalation Therapy
4
2020
184
0.480
 Why?
Disease Progression
14
2020
2871
0.480
 Why?
Managed Care Programs
8
2008
135
0.480
 Why?
Male
82
2025
71569
0.460
 Why?
Emergency Service, Hospital
9
2013
2266
0.460
 Why?
Precision Medicine
1
2020
450
0.460
 Why?
Adult
47
2025
40129
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
28
0.440
 Why?
Cost Savings
1
2015
85
0.440
 Why?
Female
81
2025
77570
0.430
 Why?
Practice Patterns, Physicians'
7
2020
1322
0.430
 Why?
Patient Reported Outcome Measures
1
2018
465
0.420
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.400
 Why?
Cost-Benefit Analysis
7
2022
616
0.400
 Why?
Middle Aged
40
2025
35630
0.380
 Why?
Phenotype
6
2025
3183
0.380
 Why?
Comorbidity
4
2021
1638
0.360
 Why?
Academic Medical Centers
3
2024
537
0.340
 Why?
Surveys and Questionnaires
14
2022
6004
0.330
 Why?
Adolescent
37
2019
22233
0.330
 Why?
Medical Records Systems, Computerized
3
2008
96
0.330
 Why?
Administration, Oral
6
2021
841
0.320
 Why?
Mentors
1
2012
214
0.320
 Why?
Quality of Life
12
2023
3142
0.320
 Why?
Respiratory Function Tests
10
2015
570
0.310
 Why?
United States
23
2022
15602
0.310
 Why?
Interprofessional Relations
3
2021
282
0.300
 Why?
Faculty, Medical
1
2012
294
0.300
 Why?
Child, Preschool
31
2016
11630
0.300
 Why?
Spirometry
8
2020
264
0.300
 Why?
Treatment Outcome
16
2025
11459
0.300
 Why?
Child Development
1
2014
494
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
45
0.280
 Why?
Oxygen
3
2018
1000
0.270
 Why?
Computer Simulation
1
2012
1032
0.270
 Why?
Aged
22
2022
25615
0.270
 Why?
Dyspnea
3
2022
257
0.260
 Why?
Drug Utilization
4
2005
163
0.250
 Why?
Randomized Controlled Trials as Topic
8
2020
1688
0.240
 Why?
Primary Health Care
5
2025
1757
0.240
 Why?
Quality Assurance, Health Care
1
2008
314
0.240
 Why?
Primary Graft Dysfunction
2
2017
35
0.240
 Why?
Follow-Up Studies
17
2017
5316
0.240
 Why?
Respiratory Sounds
1
2006
106
0.230
 Why?
Bronchiolitis Obliterans
3
2017
66
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
14
0.230
 Why?
Genetic Testing
1
2008
475
0.220
 Why?
Delivery of Health Care
2
2021
946
0.220
 Why?
Medication Adherence
2
2023
519
0.210
 Why?
Cohort Studies
14
2013
5861
0.210
 Why?
Retrospective Studies
18
2024
16754
0.210
 Why?
Specialization
2
2025
134
0.210
 Why?
Natural Language Processing
1
2025
104
0.200
 Why?
Time Factors
10
2020
7068
0.200
 Why?
Massachusetts
5
2016
182
0.200
 Why?
Leadership
2
2022
404
0.200
 Why?
Antibodies, Monoclonal
2
2008
1522
0.200
 Why?
Medicine
1
2025
125
0.200
 Why?
Genetic Variation
1
2008
990
0.190
 Why?
Rhinitis, Allergic, Perennial
1
2003
23
0.190
 Why?
Steroids
8
2011
161
0.190
 Why?
Recurrence
5
2013
1122
0.190
 Why?
Genetic Predisposition to Disease
2
2025
2407
0.190
 Why?
Health Status
1
2008
821
0.190
 Why?
Predictive Value of Tests
9
2012
2097
0.180
 Why?
Beclomethasone
1
2022
9
0.180
 Why?
Young Adult
11
2019
13914
0.180
 Why?
Multicenter Studies as Topic
4
2018
394
0.180
 Why?
Prevalence
4
2022
2819
0.180
 Why?
Models, Theoretical
4
2007
586
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.170
 Why?
Desensitization, Immunologic
1
2022
95
0.170
 Why?
Nebulizers and Vaporizers
2
2020
67
0.170
 Why?
Biomarkers
3
2021
4248
0.170
 Why?
Social Class
2
2022
270
0.170
 Why?
Patient Preference
1
2023
218
0.170
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
29
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Capacity Building
1
2021
59
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
47
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
35
0.160
 Why?
Physician-Patient Relations
2
2021
585
0.150
 Why?
Practice Guidelines as Topic
5
2020
1525
0.150
 Why?
Electronic Health Records
2
2025
1170
0.150
 Why?
Risk Factors
12
2018
10623
0.150
 Why?
Air Pollution, Indoor
2
2002
181
0.150
 Why?
Treatment Adherence and Compliance
1
2019
28
0.150
 Why?
Exercise Test
1
2022
621
0.140
 Why?
Receptors, IgE
2
2009
44
0.140
 Why?
Prognosis
8
2017
4210
0.140
 Why?
Allergens
1
2021
394
0.140
 Why?
Vitamin D
2
2012
402
0.130
 Why?
Fossil Fuels
1
1997
10
0.130
 Why?
Hypersensitivity
1
2020
265
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
269
0.130
 Why?
Biological Products
1
2020
252
0.130
 Why?
Respiration
1
2017
209
0.130
 Why?
Physicians, Primary Care
3
2021
207
0.130
 Why?
Emergency Medical Services
2
2007
685
0.130
 Why?
Respiration Disorders
1
1997
78
0.130
 Why?
Statistics, Nonparametric
1
2017
431
0.120
 Why?
Drug Combinations
3
2012
376
0.120
 Why?
Drug Therapy, Combination
5
2020
1032
0.120
 Why?
Immunomodulation
1
2017
102
0.120
 Why?
Drug Monitoring
1
2020
394
0.120
 Why?
Socioeconomic Factors
4
2022
1327
0.120
 Why?
Tobacco Smoke Pollution
2
2010
236
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Breath Tests
2
2008
81
0.120
 Why?
Aged, 80 and over
6
2019
8130
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Patient Admission
1
2018
206
0.120
 Why?
Immunoglobulin G
1
2020
899
0.120
 Why?
Cholinergic Antagonists
1
2015
23
0.120
 Why?
Transplants
1
2015
39
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
102
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
8
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
834
0.110
 Why?
Referral and Consultation
1
2021
839
0.110
 Why?
Longitudinal Studies
6
2017
2948
0.110
 Why?
Graft Rejection
2
2013
536
0.110
 Why?
Overweight
2
2011
598
0.110
 Why?
Respiratory Tract Infections
2
2012
395
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.100
 Why?
Postoperative Complications
2
2017
2894
0.100
 Why?
Prednisolone
1
2014
66
0.100
 Why?
Risk
4
2015
901
0.100
 Why?
Telemedicine
1
2023
940
0.100
 Why?
Guideline Adherence
3
2020
563
0.100
 Why?
Education, Medical, Continuing
2
2005
130
0.100
 Why?
Environmental Exposure
3
2006
584
0.100
 Why?
Airway Obstruction
1
2015
164
0.100
 Why?
Forecasting
1
2015
388
0.100
 Why?
Bronchial Hyperreactivity
3
2010
102
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Quality Improvement
1
2022
1268
0.100
 Why?
Office Visits
4
2011
91
0.100
 Why?
Insurance Claim Review
1
2013
83
0.100
 Why?
Peer Group
2
2012
250
0.090
 Why?
Medicare
2
2022
821
0.090
 Why?
Growth
1
2012
51
0.090
 Why?
Double-Blind Method
5
2010
2017
0.090
 Why?
Costs and Cost Analysis
1
2013
215
0.090
 Why?
Research
1
2015
426
0.090
 Why?
Methacholine Chloride
3
2008
50
0.090
 Why?
Cytomegalovirus Infections
2
2012
205
0.090
 Why?
Metered Dose Inhalers
1
2012
13
0.090
 Why?
Cost of Illness
3
2003
320
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Feedback
1
2012
182
0.090
 Why?
Logistic Models
5
2017
2095
0.090
 Why?
Mycoses
1
2012
88
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
982
0.090
 Why?
Antifungal Agents
1
2012
150
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
9
0.090
 Why?
Multivariate Analysis
7
2017
1508
0.090
 Why?
Professional Role
1
2012
158
0.090
 Why?
Body Height
1
2012
202
0.090
 Why?
Medication Errors
1
2012
85
0.090
 Why?
Morbidity
2
2022
322
0.080
 Why?
Epidemiologic Studies
1
2011
67
0.080
 Why?
Pneumococcal Vaccines
1
2012
129
0.080
 Why?
Mycobacterium
1
2012
115
0.080
 Why?
Obesity
3
2015
3073
0.080
 Why?
Patient Readmission
1
2016
724
0.080
 Why?
Diagnostic Errors
1
2012
176
0.080
 Why?
Secondary Prevention
1
2012
237
0.080
 Why?
Program Development
1
2012
368
0.080
 Why?
Drug Resistance
1
2011
154
0.080
 Why?
Probability
1
2011
305
0.080
 Why?
Vitamin D Deficiency
1
2012
187
0.080
 Why?
Chi-Square Distribution
2
2017
516
0.080
 Why?
Lung Diseases
1
2017
794
0.080
 Why?
Bronchial Provocation Tests
2
2008
47
0.080
 Why?
Fluticasone
2
2008
57
0.080
 Why?
Decision Support Techniques
2
2012
446
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
133
0.080
 Why?
Incidence
5
2020
2845
0.080
 Why?
Immunoglobulin E
2
2008
318
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.080
 Why?
Vital Capacity
4
2017
311
0.080
 Why?
Lectins, C-Type
1
2009
63
0.080
 Why?
Ambulatory Care
2
2011
592
0.080
 Why?
Algorithms
1
2017
1843
0.070
 Why?
Health Services
2
2007
116
0.070
 Why?
Medication Therapy Management
1
2010
72
0.070
 Why?
Proportional Hazards Models
1
2012
1305
0.070
 Why?
Odds Ratio
4
2017
1057
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1402
0.070
 Why?
Smoking
3
2017
1556
0.070
 Why?
Surgical Wound Infection
1
2012
327
0.070
 Why?
Acute Disease
1
2011
996
0.070
 Why?
Pandemics
3
2022
1675
0.070
 Why?
Kaplan-Meier Estimate
3
2016
957
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
11
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
19
0.070
 Why?
Cross-Sectional Studies
6
2010
5761
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
47
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
47
0.070
 Why?
Program Evaluation
1
2012
947
0.070
 Why?
Adrenergic beta-Agonists
1
2008
95
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
114
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
23
0.070
 Why?
Markov Chains
2
2006
125
0.070
 Why?
State Health Plans
1
2008
28
0.070
 Why?
Trastuzumab
1
2008
111
0.070
 Why?
Cost Sharing
1
2008
20
0.070
 Why?
Smoking Cessation
1
2012
434
0.070
 Why?
Reimbursement Mechanisms
1
2008
78
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
51
0.070
 Why?
Chronic Disease
3
2017
1826
0.070
 Why?
Omalizumab
1
2007
43
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
365
0.060
 Why?
Factor Analysis, Statistical
1
2008
289
0.060
 Why?
Exercise Tolerance
2
2022
288
0.060
 Why?
Health Surveys
2
2006
509
0.060
 Why?
Warfarin
1
2008
165
0.060
 Why?
Interviews as Topic
1
2011
884
0.060
 Why?
Influenza Vaccines
1
2012
524
0.060
 Why?
Antiviral Agents
1
2012
743
0.060
 Why?
Databases, Factual
1
2012
1459
0.060
 Why?
Animals, Domestic
1
2006
18
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2782
0.060
 Why?
Lung Diseases, Interstitial
1
2013
663
0.060
 Why?
Health Services Accessibility
2
2021
1078
0.060
 Why?
Animals
2
2025
38140
0.060
 Why?
Physicians, Family
2
2004
174
0.060
 Why?
Eosinophils
1
2008
324
0.060
 Why?
Biomedical Research
1
2012
709
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Database Management Systems
1
2005
50
0.060
 Why?
Hip Fractures
1
2006
85
0.050
 Why?
Health Policy
1
2008
390
0.050
 Why?
Models, Biological
1
2012
1833
0.050
 Why?
Insurance Coverage
1
2006
236
0.050
 Why?
Patients
1
2006
179
0.050
 Why?
Utilization Review
1
2004
37
0.050
 Why?
Infant
3
2008
9885
0.050
 Why?
Body Mass Index
3
2015
2439
0.050
 Why?
Patient Education as Topic
3
2005
791
0.050
 Why?
Gene Expression Profiling
1
2011
1817
0.050
 Why?
Clinical Competence
1
2012
1226
0.050
 Why?
Medicaid
1
2008
455
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
667
0.050
 Why?
Mass Screening
1
2012
1325
0.050
 Why?
Vaccination
1
2012
1414
0.050
 Why?
Nitric Oxide
1
2008
903
0.050
 Why?
Attitude to Health
1
2006
436
0.050
 Why?
Sex Factors
3
2016
2078
0.050
 Why?
Anticoagulants
1
2008
718
0.050
 Why?
Case Management
1
2003
65
0.050
 Why?
Clinical Trials as Topic
2
2005
1047
0.050
 Why?
Puerto Rico
1
2022
54
0.050
 Why?
Parents
3
2006
1414
0.050
 Why?
Choice Behavior
1
2004
177
0.050
 Why?
Anti-Bacterial Agents
2
2004
1901
0.050
 Why?
Symptom Flare Up
1
2022
37
0.050
 Why?
Sputum
1
2004
314
0.040
 Why?
Academies and Institutes
1
2022
61
0.040
 Why?
Circadian Rhythm
1
2006
516
0.040
 Why?
Health Services Research
1
2004
395
0.040
 Why?
Lung Neoplasms
1
2015
2636
0.040
 Why?
Minority Groups
1
2003
280
0.040
 Why?
Survival Rate
2
2016
2034
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
78
0.040
 Why?
Electronics
1
2021
74
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
118
0.040
 Why?
Sample Size
1
2020
122
0.040
 Why?
Efficiency
1
2021
103
0.040
 Why?
Health Care Reform
1
2021
108
0.040
 Why?
Risk Assessment
3
2020
3556
0.040
 Why?
Schools, Medical
1
2021
158
0.040
 Why?
Patient Selection
2
2020
695
0.040
 Why?
Language
1
2022
322
0.040
 Why?
Patient Compliance
2
2016
612
0.040
 Why?
Stress, Psychological
1
2007
1147
0.040
 Why?
Time
1
2019
88
0.040
 Why?
Cluster Analysis
2
2014
530
0.040
 Why?
Health Education
1
2002
358
0.040
 Why?
Quality of Health Care
1
2003
649
0.040
 Why?
Poland
1
2017
35
0.030
 Why?
Republic of Korea
1
2017
42
0.030
 Why?
Bronchitis, Chronic
1
2017
24
0.030
 Why?
Cooperative Behavior
1
2021
460
0.030
 Why?
Patient-Centered Care
1
2003
542
0.030
 Why?
Sensitivity and Specificity
3
2013
1984
0.030
 Why?
Nitrogen Dioxide
1
1997
46
0.030
 Why?
Geography
1
2018
202
0.030
 Why?
Aftercare
1
2019
217
0.030
 Why?
Pediatrics
1
2005
1080
0.030
 Why?
Long-Term Care
1
2018
115
0.030
 Why?
Self Concept
1
2019
253
0.030
 Why?
Monitoring, Physiologic
2
2012
291
0.030
 Why?
Netherlands
1
2016
83
0.030
 Why?
Antineoplastic Agents
1
2008
2220
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
131
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Salmeterol Xinafoate
1
2015
22
0.030
 Why?
Ethanolamines
1
2015
15
0.030
 Why?
Perception
1
2019
378
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
35
0.030
 Why?
Treatment Failure
1
2016
363
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2030
0.030
 Why?
Feasibility Studies
1
2020
1065
0.030
 Why?
Education
1
2015
107
0.030
 Why?
Self Efficacy
1
2019
411
0.030
 Why?
Postoperative Period
1
2016
353
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2167
0.030
 Why?
Immunosuppressive Agents
2
2015
843
0.030
 Why?
Age Factors
3
2008
3288
0.030
 Why?
Fatal Outcome
1
2015
306
0.030
 Why?
Biopsy
2
2013
1068
0.030
 Why?
Pilot Projects
1
2020
1851
0.030
 Why?
Combined Modality Therapy
1
2017
1260
0.030
 Why?
Patient Acceptance of Health Care
1
2021
872
0.030
 Why?
Gene Expression
1
2018
1512
0.020
 Why?
Telephone
2
2005
175
0.020
 Why?
Echinocandins
1
2012
7
0.020
 Why?
Lipopeptides
1
2012
16
0.020
 Why?
Aspergillosis
1
2012
23
0.020
 Why?
Amphotericin B
1
2012
37
0.020
 Why?
Intention to Treat Analysis
1
2012
76
0.020
 Why?
Tissue Donors
1
2015
413
0.020
 Why?
Candidiasis
1
2012
64
0.020
 Why?
Transplantation, Homologous
1
2013
414
0.020
 Why?
Age Distribution
2
2003
395
0.020
 Why?
Mycobacterium avium Complex
1
2012
89
0.020
 Why?
Cromolyn Sodium
2
2001
5
0.020
 Why?
Hypoxia
1
2019
1199
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
375
0.020
 Why?
Triazoles
1
2012
181
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Self Care
2
2005
398
0.020
 Why?
Reference Values
1
2012
806
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Colorado
1
2021
4578
0.020
 Why?
Principal Component Analysis
1
2011
199
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
208
0.020
 Why?
Health
1
2010
83
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1446
0.020
 Why?
Environment
1
2011
306
0.020
 Why?
Observation
1
2008
51
0.020
 Why?
Sex Ratio
1
2008
16
0.020
 Why?
Least-Squares Analysis
1
2008
77
0.020
 Why?
Models, Econometric
1
2008
35
0.020
 Why?
Prospective Studies
2
2012
7900
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
94
0.020
 Why?
Intelligence
1
2007
117
0.020
 Why?
Social Isolation
1
2007
72
0.020
 Why?
Puberty
1
2008
154
0.020
 Why?
Body Weight
1
2011
993
0.020
 Why?
Child Behavior Disorders
1
2007
125
0.020
 Why?
Exercise
1
2016
2196
0.010
 Why?
Insurance, Health
1
2007
296
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1133
0.010
 Why?
Genotype
1
2009
1837
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
127
0.010
 Why?
Health Status Indicators
1
2004
162
0.010
 Why?
Case-Control Studies
1
2010
3614
0.010
 Why?
Systems Integration
1
2003
38
0.010
 Why?
Computer Systems
1
2003
56
0.010
 Why?
Motor Activity
1
2007
722
0.010
 Why?
Histamine H1 Antagonists
1
2002
26
0.010
 Why?
Drug Administration Schedule
1
2004
779
0.010
 Why?
Self Disclosure
1
2002
65
0.010
 Why?
Child Welfare
1
2004
229
0.010
 Why?
Administration, Intranasal
1
2002
93
0.010
 Why?
Confidence Intervals
1
2002
330
0.010
 Why?
Regression Analysis
1
2003
1003
0.010
 Why?
Nurse's Role
1
2003
171
0.010
 Why?
Point-of-Care Systems
1
2003
187
0.010
 Why?
Health Care Surveys
1
2002
535
0.010
 Why?
Sex Distribution
1
2001
379
0.010
 Why?
Patient Satisfaction
1
2004
700
0.010
 Why?
Linear Models
1
2002
857
0.010
 Why?
Disease Management
1
2003
639
0.010
 Why?
Decision Support Systems, Clinical
1
2003
267
0.010
 Why?
Bronchoscopy
1
2000
227
0.010
 Why?
Caregivers
1
2007
1025
0.010
 Why?
Internet
1
2003
699
0.010
 Why?
Pregnancy
1
2010
7154
0.010
 Why?
Survival Analysis
1
2000
1358
0.010
 Why?
Infant, Newborn
1
2004
6362
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)